Inno-Syringe™ Low Dead Space Syringe Fixed Needle

Inno-Syringe™: up to 40% more vaccinations from the same vial

Inno-Syringe™ is the name of the innovative 'Low Dead Space Syringe' developed by the Pharma subsidiary of the Rockmed Group. The syringe with a very low dead volume has the main advantage of only 3.5 microliters (µl) remaining in the syringe. In practice, this means that instead of five as many as seven doses can be obtained from a vial. This makes the patented and CE-approved Innu-Syringe ideal for the current COVID-19 vaccination campaign.

  • Cannula staked with syringe directly as an insulin syringe
  • Minimum dead space between cannula and rubber
  • Lowest medication residue and waste
  • Minimal residual volume
  • Currently used for accurate low dose injections
  • More vaccination with the same amount of medicine
  • Available directly from stock

Would you like to find out more?
Feel free to contact us.

LDSS LL innopharmaweb